Written by Dan Goldstein (Partner and Co-Founder), Kamal Govindaswamy (Partner and Co-Founder) and Monica Meiterman-Rodriguez (Privacy Consultant). Healthcare Information Technology (Health IT) in the United States has undergone considerable change …
DATA PROTECTION
Building the Privacy Balance Sheet in VC and PE Portfolios
By Rob McWilliams, Consultant – Tueoris In a global economy that is more reliant than ever on digital information, personal data is a high-value asset that carries corresponding risks. …
How Deep Must We Dig? Fulfilling Data Subject Access Requests From Current and Former Employees
By Mayra Cavazos, Senior Consultant, Tueoris, LLC Responding in an appropriate and adequate manner to data subject access requests from employees or former employees in the European Union (“EU”) is …
EU Privacy and US Trade Limitations: Opening New Opportunities for Mexican Business
By Mayra Cavazos, Senior Consultant, Tueoris, LLC Introduction The European Union (EU) General Data Protection Regulation (GDPR) has impacted businesses around the world in a variety of different ways, influenced …
Alternatives to Consent: New Approaches to Processing Patient Data for Current and Future Clinical Research
Introduction Pharmaceutical and biotech companies sponsoring clinical research have traditionally relied on patient consent as the legal basis for processing personal data, sensitive personal data and biologic material for …